Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

67,570 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Minor clone of del(17p) provides a reservoir for relapse in multiple myeloma.
Cui J, Lv R, Yu T, Yan W, Xu J, Fan H, Li L, Liu Y, Du C, Deng S, Sui W, Xu Y, Yi S, Zou D, Qiu L, An G. Cui J, et al. Among authors: xu y, xu j. Haematologica. 2024 Feb 1;109(2):591-603. doi: 10.3324/haematol.2023.283533. Haematologica. 2024. PMID: 37534514 Free PMC article. Clinical Trial.
Favorable outcomes of front-line risk-adapted therapy in young patients with diffuse large B-cell lymphoma with clinically or biologically high-risk features.
Zou H, Liu W, Wang Y, Shan D, Xie T, Li R, Liu H, Huang W, Fu M, Wang T, Lv R, Deng S, Sui W, Xu Y, Yi S, An G, Qiu L, Zou D. Zou H, et al. Among authors: xu y. Chin Med J (Engl). 2023 Dec 7. doi: 10.1097/CM9.0000000000002940. Online ahead of print. Chin Med J (Engl). 2023. PMID: 38061986 No abstract available.
Development and validation of an individualized and weighted Myeloma Prognostic Score System (MPSS) in patients with newly diagnosed multiple myeloma.
Mao X, Yan W, Mery D, Liu J, Fan H, Xu J, Xu Y, Sui W, Deng S, Zou D, Du C, Yi S, van Rhee F, Barlogie B, Shaughnessy JD Jr, Anderson KC, Zhan F, Qiu L, An G. Mao X, et al. Among authors: xu y, xu j. Am J Hematol. 2024 Apr;99(4):523-533. doi: 10.1002/ajh.27207. Epub 2024 Jan 21. Am J Hematol. 2024. PMID: 38247315
Dynamic monitoring of circulating tumor DNA reveals outcomes and genomic alterations in patients with relapsed or refractory large B-cell lymphoma undergoing CAR T-cell therapy.
Zou H, Liu W, Wang X, Wang Y, Wang C, Qiu C, Liu H, Shan D, Xie T, Huang W, Sui W, Yi S, An G, Xu Y, Ma T, Wang J, Qiu L, Zou D. Zou H, et al. Among authors: xu y. J Immunother Cancer. 2024 Mar 4;12(3):e008450. doi: 10.1136/jitc-2023-008450. J Immunother Cancer. 2024. PMID: 38443094 Free article.
Combinational therapy of CAR T-cell and HDT/ASCT demonstrates impressive clinical efficacy and improved CAR T-cell behavior in relapsed/refractory large B-cell lymphoma.
Liu W, Liu W, Zou H, Chen L, Huang W, Lv R, Xu Y, Liu H, Shi Y, Wang K, Wang Y, Xiong W, Deng S, Yi S, Sui W, Peng G, Ma Y, Wang H, Lv L, Wang J, Wei J, Qiu L, Zheng W, Zou D. Liu W, et al. Among authors: xu y. J Immunother Cancer. 2024 Apr 16;12(4):e008857. doi: 10.1136/jitc-2024-008857. J Immunother Cancer. 2024. PMID: 38631712 Free PMC article.
67,570 results
You have reached the last available page of results. Please see the User Guide for more information.